July 26, 2021

Shingrix Approval Expanded to Include Immunocompromised Adults Under the Age of 50

Read More
July 23, 2021

Bydureon BCise Now Indicated to Treat Type 2 Diabetes in Children

Read More
July 23, 2021

Dalvance Now Indicated to Treat Acute Bacterial Skin and Skin Structure Infections in Children as Well as Adults

Read More
July 20, 2021

First FDA-Approved Medication for Rare Liver Disorder Launched

Read More
July 20, 2021

FDA Requests Removal of Warning Against Statin Use in Pregnant Individuals

Read More
July 20, 2021

Amidst Chantix Recall, FDA Allows Import of Canadian Therapeutic Alternative

Read More
July 20, 2021

Octagam Receives Indication for Rare Disease of the Muscle Tissues

Read More
July 16, 2021

New Oral Treatment for Sleeping Sickness Approved

Read More
July 16, 2021

Vaxneuvance Approved to Prevent Pneumococcal Disease

Read More
July 16, 2021

FDA Approves First-in-Class Treatment for Chronic Graft-Versus-Host Disease

Read More
July 16, 2021

Prograf Becomes First FDA-Approved Drug to Prevent Organ Rejection in Adult and Pediatric Lung Transplant Recipients

Read More
July 12, 2021

Darzalex Faspro Receives New Multiple Myeloma Indication

Read More